P-ISSN 2587-2400 | E-ISSN 2587-196X
EJMO Sponsors
- Amgen
- Roche
- Astellas
- AstraZeneca
- Bristol-Myers Squibb
- Johnson Johnson
- Merck
- Pfizer
- Novartis
- Omnigen
- Mustafa Nevzat
- Arven
- TEVA
- Trpharm
SARS-CoV-2 Related Protein Expression May Predict Vulnerability for Developing COVID-19 in Cancer Patients